SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001683168-20-000505
Filing Date
2020-02-14
Accepted
2020-02-14 15:28:30
Documents
8

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 5893
2 AMENDMENT NO. 6 cbd_1aa6.htm PART II AND III 1814662
3 OPINION OF LUX LAW, P.A. cbd_ex-1201.htm EX1A-12 OPN CNSL 6369
4 GRAPHIC logo.jpg GRAPHIC 34896
5 GRAPHIC image_001.jpg GRAPHIC 9809
6 GRAPHIC image_002.jpg GRAPHIC 2543
7 GRAPHIC image_005.jpg GRAPHIC 3173
8 GRAPHIC image_003.jpg GRAPHIC 4722
  Complete submission text file 0001683168-20-000505.txt   1904633
Mailing Address 10855 N. 116TH STREET, SUITE 115 SCOTTSDALE AZ 85259
Business Address 10855 N. 116TH STREET, SUITE 115 SCOTTSDALE AZ 85259 480-410-6780
CBD Life Sciences Inc. (Filer) CIK: 0001776073 (see all company filings)

IRS No.: 205118532 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 1-A/A | Act: 33 | File No.: 024-11005 | Film No.: 20618715
SIC: 2833 Medicinal Chemicals & Botanical Products